Page last updated: 2024-08-26

cb 10375 and nsc 262266

cb 10375 has been researched along with nsc 262266 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Flora, KP; Halbert, GW; Henrar, RE; Slack, JA1

Other Studies

1 other study(ies) available for cb 10375 and nsc 262266

ArticleYear
CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs.
    British journal of cancer, 1995, Volume: 72, Issue:1

    Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bryostatins; Chemistry, Pharmaceutical; Drug Stability; Excipients; Imidazoles; Isoquinolines; Lactones; Macrolides; Quaternary Ammonium Compounds; Solubility; Triazines

1995